ClinicalTrials.Veeva

Menu

Effects of BLa80 and LRa05 on the Gut Microbiota Metabolite Profile of Healthy Individuals

W

Wecare Probiotics

Status

Enrolling

Conditions

Healthy Individuals

Treatments

Dietary Supplement: Placebo
Dietary Supplement: LRa05
Dietary Supplement: BLa80

Study type

Interventional

Funder types

Industry

Identifiers

NCT07287306
WK20251120

Details and patient eligibility

About

Gut microbiota play a key role in polyphenol metabolism, participating in the breakdown of dietary components and producing various small molecule metabolites that affect human health. However, little is currently known about how gut microbes metabolize dietary compounds and produce bioactive metabolites. This study aims to use metabolomics to precisely identify food-derived metabolites in the blood to investigate whether probiotics (BLa80, LRa05) can enhance the breakdown of dietary components and improve their absorption and utilization in the human body.

Enrollment

375 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Male or female participants aged 18 to 60 years;
  2. Healthy individuals;
  3. Participants must provide written informed consent.

Exclusion criteria

  1. History of gastrointestinal surgery, other gastrointestinal diseases, metabolic disorders, immunodeficiency, hyperthyroidism, or cardiac or liver disease;
  2. Use of immunosuppressants;
  3. Pregnant or breastfeeding women;
  4. Participants who have taken antibiotics or probiotics within the previous 3 months;
  5. Planned surgery during the study period;
  6. Patients with neurological disorders or psychiatric illness.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

375 participants in 3 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Each placebo stick contained 3 g of dextrin. Dosage: one stick per day.
Treatment:
Dietary Supplement: Placebo
BLa80
Experimental group
Description:
Each probiotic stick contained dextrin and 2 × 10¹⁰ CFU BLa80. Dosage: one stick per day.
Treatment:
Dietary Supplement: BLa80
LRa05
Experimental group
Description:
Each probiotic stick contained dextrin and 2 × 10¹⁰ CFU LRa05. Dosage: one stick per day.
Treatment:
Dietary Supplement: LRa05

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems